About the Authors
- Jardin A. Leleux
-
Contributed equally to this work with: Jardin A. Leleux, Tina C. Albershardt
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing
* E-mail: jardin.leleux@gmail.com
Affiliation Immune Design Corp., Seattle, WA, A wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, United States of America
- Tina C. Albershardt
-
Contributed equally to this work with: Jardin A. Leleux, Tina C. Albershardt
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing
Affiliation Immune Design Corp., Seattle, WA, A wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, United States of America
- Rebecca Reeves
-
Roles Investigation
Affiliation Immune Design Corp., Seattle, WA, A wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, United States of America
- Reice James
-
Roles Investigation
Affiliation Immune Design Corp., Seattle, WA, A wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, United States of America
- Jordan Krull
-
Roles Investigation
Affiliation Immune Design Corp., Seattle, WA, A wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, United States of America
- Andrea J. Parsons
-
Roles Investigation
Affiliation Immune Design Corp., Seattle, WA, A wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, United States of America
- Jan ter Meulen
-
Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing
Affiliation Immune Design Corp., Seattle, WA, A wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, United States of America
- Peter Berglund
-
Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing
Affiliation Immune Design Corp., Seattle, WA, A wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, United States of America
Competing Interests
All authors were employees of Immune Design at the time of data generation and held stock and/or options in Immune Design at that time. Additionally, all authors were inventors on relevant patent applications assigned to Immune Design for inventions discussed in this paper. This does not alter our adherence to PLOS ONE policies on sharing data and materials.